Elhan Webb
Investor Relations Contact at KARYOPHARM THERAPEUTICS INC.
Elhan Webb active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | 2022-03-13 | - |
Career history of Elhan Webb
Former positions of Elhan Webb
| Companies | Position | Start | End |
|---|---|---|---|
| ROCHE HOLDING AG | Public Communications Contact | - | - |
| RUBIUS THERAPEUTICS | Investor Relations Contact | 2020-10-31 | - |
| RADIUS HEALTH, INC. | Investor Relations Contact | 2018-01-01 | - |
| Public Communications Contact | 2018-01-01 | - |
Training of Elhan Webb
| University of Southern California | Masters Business Admin |
| Bogazici University | Undergraduate Degree |
Statistics
International
| United States | 6 |
| Turkey | 2 |
Operational
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Stock Market
- Insiders
- Elhan Webb
- Experience
